German American Bancorp, Inc. Bristol Myers Squibb CO Transaction History

German American Bancorp, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $200,415 - $224,095	3,462 New	3,462 $200,000
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $22,730 - $25,033	-313 Reduced 9.27%	3,062 $236,000
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $33,199 - $39,808	-540 Reduced 13.79%	3,375 $246,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $5,309 - $6,189	99 Added 2.59%	3,915 $244,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $7,396 - $8,663	-125 Reduced 3.17%	3,816 $226,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $4,024 - $4,382	-65 Reduced 1.62%	3,941 $263,000
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $17,980 - $20,222	303 Added 8.18%	4,006 $253,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $17,610 - $19,956	305 Added 8.98%	3,703 $230,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $195,147 - $216,248	3,398 New	3,398 $205,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $171,587 - $249,356	-3,698 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$49.21 - $64.19 $181,978 - $237,374	3,698 New	3,698 $237,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of German American Bancorp, Inc., based on Form 13F filings with the SEC.

Stay updated on German American Bancorp, Inc. with notifications on news.